Home / MARKSANS.NS : NSE

AI Analysis Fundamentals Valuation Video Analysis News Similar

AI Analysis

How does MARKSANS.NS make money? Does MARKSANS.NS have pricing power? What's the Earnings Whisper? Will MARKSANS.NS profit more as the business scales? What is MARKSANS.NS's management track record? Is MARKSANS.NS's current price justified?

Marksans Pharma Limited

₹311 +$131.13 (+72.90%)

NSE · 16 Oct 2026 09:59 UTC

Previous Close

₹307.85

Day Range

₹306₹313.5

Year Range

₹155₹350.95

Market Cap

140.93B

AVG Volume

2.98M

Trailing/Forward PE

27.26/20.39

PEG ratio

0.59

Dividend Yield

0.29%

Next Earnings Date

2026-11-05

Primary Exchange

National Stock Exchange of India

Revenue (INR) · A

MARKSANS.NS Revenue (INR) by year
Period	Revenue (INR)
2026	29.51B
2025	26.23B
2024	21.77B
2023	18.52B
2022	14.8B
2021	13.68B
2020	11.2B
2019	9.87B
2018	9.13B
2017	7.67B

Net Income (INR) · A

MARKSANS.NS Net Income (INR) by year
Period	Net Income (INR)
2026	4.18B
2025	3.81B
2024	3.14B
2023	2.66B
2022	1.87B
2021	2.39B
2020	1.21B
2019	794.84M
2018	329.4M
2017	95.19M

Operating Income (INR) · A

MARKSANS.NS Operating Income (INR) by year
Period	Operating Income (INR)
2026	5.02B
2025	6.28B
2024	4.03B
2023	3.3B
2022	2.14B
2021	3.19B
2020	1.56B
2019	1.07B
2018	448.56M
2017	155.3M

EBITDA · A

Cash Flows · A

EPS · A

Expenses · A

Cash & Debt · A

Debt ratios · A

Margins · A

Return on Capital · A

Shares Outstanding · A

Dividends (INR) · A

Employee Count

Book Value Per Share · A

Total Assets · A

PE Ratio

Free Cash Flow Yield

Price to Sales

EV/EBITDA

Price/Operating Cashflow

Price to Book

No video analysis for this stock yet. Request one from our team.

AI Analysis

Marksans Pharma Limited

Video analysis: MARKSANS.NS

News: MARKSANS.NS

Similar companies